Jennifer Sucre
-
Vanderbilt researchers envision the potential to grow new lungs
Using a four-dimensional microscope that allows them to watch a tissue putting itself together, researchers at Vanderbilt University Medical Center have achieved a rare feat in science — they have shattered a long-standing dogma about how the lung develops. Read MoreJul 5, 2023
-
“Atlas” of lung development may aid efforts to heal premature lungs
Researchers at Vanderbilt University Medical Center have constructed a single-cell “atlas” of lung development that tracks multiple cell types over time. Read MoreDec 20, 2021
-
Why does COVID-19 seem to spare children? Vanderbilt University Medical Center study offers an answer
Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. Read MoreNov 18, 2020
-
Research probes why COVID-19 seems to spare young children
Lung disease experts at Vanderbilt University Medical Center and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. Read MoreMay 28, 2020
-
Clues to lung injury in preterm babies
Jennifer Sucre and colleagues have discovered a factor that contributes to the pathological changes of bronchopulmonary dysplasia, the most common complication of preterm birth. Read MoreMar 5, 2020
-
Department of Cell and Developmental Biology Seminar
Jennifer Sucre, Assistant Professor of Pediatrics, Division of Neonatology at Vanderbilt University Medical School and Secondary Faculty Candidate for CDB presents “Modeling the Lung: Wnt Signaling in Lung Development and Disease”. Read MoreJun 20, 2019
-
Lung diseases share molecular signature
Lung diseases of infancy and aging share a molecular signature, pointing to a potential target for treatment and prevention. Read MoreApr 5, 2018
-
A target to heal tiny lungs
The protein beta-catenin may be a good target for therapies to treat lung disease that is a common complication of preterm birth. Read MoreFeb 23, 2017